Technical Analysis for PTI - Proteostasis Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.1 5.80% 0.17
PTI closed up 5.8 percent on Friday, June 22, 2018, on 4.36 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical PTI trend table...

Date Alert Name Type % Chg
Jun 22 Volume Surge Other 0.00%
Jun 22 Wide Bands Range Expansion 0.00%
Jun 22 Oversold Stochastic Weakness 0.00%
Jun 21 Wide Bands Range Expansion 5.80%
Jun 21 Oversold Stochastic Weakness 5.80%
Jun 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.64%
Jun 20 Narrow Range Bar Range Contraction 1.64%
Jun 20 Wide Bands Range Expansion 1.64%
Jun 20 Oversold Stochastic Weakness 1.64%
Jun 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.31%

Older signals for PTI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Proteostasis Therapeutics, Inc., a biopharmaceutical company, develops therapeutics to treat protein conformational diseases. The company offers disease-modifying therapeutics for cystic fibrosis; and also develops treatments for diseases caused by an imbalance in the proteostasis network and characterized by defects in protein folding, trafficking, and clearance, including genetic, neurodegenerative, and retinal degenerative diseases. Its lead product candidate is PTI-428, an orally bioavailable cystic fibrosis transmembrane conductance regulator modulator belonging to the amplifier class. The company was formerly known as Proteoguard, Inc. and changed its name to Proteostasis Therapeutics, Inc. in September 2007. The company was founded in 2006 and is based in Cambridge, Massachusetts.
Is PTI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.61
52 Week Low 1.41
Average Volume 736,049
200-Day Moving Average 3.7086
50-Day Moving Average 4.5738
20-Day Moving Average 3.7255
10-Day Moving Average 2.968
Average True Range 0.2959
ADX 30.17
+DI 17.87
-DI 35.27
Chandelier Exit (Long, 3 ATRs ) 4.2723
Chandelier Exit (Short, 3 ATRs ) 3.5677
Upper Bollinger Band 5.5879
Lower Bollinger Band 1.8631
Percent B (%b) 0.33
BandWidth 99.981211
MACD Line -0.5171
MACD Signal Line -0.4969
MACD Histogram -0.0203
Fundamentals Value
Market Cap 77.81 Million
Num Shares 25.1 Million
EPS -2.19
Price-to-Earnings (P/E) Ratio -1.42
Price-to-Sales 6.19
Price-to-Book 0.96
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.60
Resistance 3 (R3) 3.57 3.37 3.51
Resistance 2 (R2) 3.37 3.25 3.39 3.48
Resistance 1 (R1) 3.24 3.17 3.31 3.27 3.46
Pivot Point 3.04 3.04 3.08 3.06 3.04
Support 1 (S1) 2.91 2.92 2.98 2.94 2.74
Support 2 (S2) 2.71 2.84 2.73 2.72
Support 3 (S3) 2.58 2.71 2.69
Support 4 (S4) 2.61